CHD1 and ovarian carcinoma: For example, miR-30a-5p targets CHD1 and enhances the cisplatin sensitivity of ovarian cancer cells through the Wnt/β-catenin pathway [172]; miR-141-3p contributes to the regulation of cardiomyocyte apoptosis and consequently cardiovascular diseases through interaction with CHD8 [167], whereas miR-130b-3p promotes colorectal cancer progression by targeting CHD9 [166].